|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5-6
|
|
pubmed:dateCreated |
2010-9-14
|
|
pubmed:abstractText |
This study was conducted to evaluate the efficacy and safety of S-1, an oral fluoropyrimidine derivative, in Japanese patients with castration-resistant prostate cancer (CRPC). The primary endpoint was prostate-specific antigen (PSA) response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase,
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases,
http://linkedlifedata.com/resource/pubmed/chemical/Bilirubin,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination),
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0232
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2010 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
323-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20699624-Adult,
pubmed-meshheading:20699624-Aged,
pubmed-meshheading:20699624-Alanine Transaminase,
pubmed-meshheading:20699624-Androgen Antagonists,
pubmed-meshheading:20699624-Anorexia,
pubmed-meshheading:20699624-Antimetabolites, Antineoplastic,
pubmed-meshheading:20699624-Aspartate Aminotransferases,
pubmed-meshheading:20699624-Bilirubin,
pubmed-meshheading:20699624-Body Surface Area,
pubmed-meshheading:20699624-Dose-Response Relationship, Drug,
pubmed-meshheading:20699624-Drug Combinations,
pubmed-meshheading:20699624-Drug Tolerance,
pubmed-meshheading:20699624-Humans,
pubmed-meshheading:20699624-Lymphatic Metastasis,
pubmed-meshheading:20699624-Male,
pubmed-meshheading:20699624-Middle Aged,
pubmed-meshheading:20699624-Orchiectomy,
pubmed-meshheading:20699624-Oxonic Acid,
pubmed-meshheading:20699624-Prostate-Specific Antigen,
pubmed-meshheading:20699624-Prostatic Neoplasms,
pubmed-meshheading:20699624-Safety,
pubmed-meshheading:20699624-Tegafur,
pubmed-meshheading:20699624-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study.
|
|
pubmed:affiliation |
Department of Urology and Andrology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan. akazah@md.tsukuba.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
